Erudio Healtherudio.com
Drug
Arcotatug tavatecan trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying arcotatug tavatecan: G-HOPE-001. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| G-HOPE-001 NCT06238843 · Innovent Biologics (Suzhou) Co. Ltd. | CLDN18.2-positive HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma | Phase 3 | 116 | 29 | Focused | Nov 13, 2026 | Preview |